PHARMACYTE BIOTECH INC (PMCB) Stock Income Statement
NASDAQ:PMCB • US71715X2036
Current stock price
0.6879 USD
+0.03 (+5.33%)
Last:
| TTM (2026-1-31) | 2025 (2025-4-30) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 5.38M | 4.38M | 6.52M | 6.46M | 4.39M | |||
| Research and Development | 456.10K | 438.40K | 407.40K | 470.00K | 690.00K | |||
| Selling, General, and Administrative Expenses | 7.46M | 3.94M | 6.11M | 5.99M | 3.70M | |||
| Operating Income | -5.38M | -4.38M | -6.52M | -6.46M | -4.39M | |||
| Interest Income/Expense | 15.66M | 28.88M | 4.49M | 1.94M | 160.00K | |||
| Other Income/Expense | -11.65M | 8.17M | 5.94M | 200.00K | 0.00 | |||
| Non Recurring Items | 106.00K | 0.00 | -2.00M | N/A | 0.00 | |||
| Income Before Taxes | -3.28M | 30.66M | 333.80K | -4.32M | -4.24M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -7.49M | 23.36M | -17.24M | -4.32M | -4.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.05 | 3.19 | -1.80 | -0.22 | -0.27 | |||
| Statistics | ||||||||
All data in USD